June 12, 2020-June 18, 2020 The Rare Disease Clinical Outcome Assessment Consortium: Aiming to Fulfill Unmet Drug Development Endpoint Measurement Needs Presented at the DIA Virtual Global Annual Meeting, held June 12 – 18, 2020.
May 6, 2020 Webinar: What you want and need to know about the Rare Disease Cures Accelerator – Data and Analytics Platform (May 6, 2020)
April 27, 2020 Critical Path for Parkinson’s Consortium 3DT Initiative: Early regulatory engagement to optimize paths for efficient use of digital health technologies in PD clinical trials A subset of CPP member organizations* have convened to collaborate precompetitively with the goal of optimizing the efficiency of
October 21, 2019 Towards EMA Qualification of Islet Auto-Antibodies as a Model-Based Clinical Trial Enrichment Platform for Type-1 Diabetes Prevention Studies
September 23, 2019 Enabling efficient use of digital health technologies to support Parkinson’s disease drug development through precompetitive collaboration
June 25, 2019 Best Practices for the Electronic Migration and Implementation of Clinician-Reported Outcome Assessments in Clinical Trials